Health and economic burden of hpv-related diseases in singapore

Jeffrey Jen Hui Low, Yu Ko, Arunachalam Ilancheran, Xu Hao Zhang, Puneet K. Singhal, Sun Kuie Tay

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: To assess the health and economic burden of human papillomavirus (HPV)-related diseases (cervical cancer, cervical intraepithelial neoplasia (CIN) 1/2/3, and genital warts) in Singapore over a period of 25 years beginning in 2008. Methods: Incidence-based modeling was used to estimate the incidence cases and associated economic burden, with the assumption that age-stratified incidence rates will remain the same throughout the period of 25 years. The incidence rates in 2008 were projected based on data obtained from the National Cancer Registry for cervical cancer, and from a combination of published data and hospital registry review for CIN1/2/3 and genital warts. The population growth rate was factored into the projection of incidence cases over time. Direct cost data per cervical cancer and per CIN1/2/3 case were obtained from the financial database of large local hospitals while cost data for genital warts were obtained from the National Skin Center; these costs were multiplied by the number of incidence cases to produce an aggregate estimate of the economic burden over the 25-year period (in 2008 Singapore dollars) using a 3% discount rate. Results: The total number of incidence cases of HPV-disease over 25 years beginning in 2008 was estimated to be 60,183, including 8,078 for cervical cancer, 11,685 for CIN 2/3, 8,849 for CIN1, and 31,572 for genital warts. The estimated total direct cost was 83.2 million Singapore Dollars over 25 years: 57.6 million attributable to cervical cancer, 13.0 million to CIN2/3, 6.83 million to CIN1, and 5.70 million to genital warts. Conclusion: HPV-related diseases are expected to impose significant health and economic burden on the Singapore healthcare resources in the next 25 years.

Original languageEnglish
Pages (from-to)305-308
Number of pages4
JournalAsian Pacific Journal of Cancer Prevention
Volume13
Issue number1
DOIs
Publication statusPublished - 2012
Externally publishedYes

Fingerprint

Singapore
Condylomata Acuminata
Economics
Uterine Cervical Neoplasms
Incidence
Health
Cervical Intraepithelial Neoplasia
Costs and Cost Analysis
Registries
Hospital Costs
Population Growth
Databases
Delivery of Health Care
Skin
Neoplasms

Keywords

  • Cost of illness
  • Human papillomavirus
  • Singapore

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

Health and economic burden of hpv-related diseases in singapore. / Low, Jeffrey Jen Hui; Ko, Yu; Ilancheran, Arunachalam; Zhang, Xu Hao; Singhal, Puneet K.; Tay, Sun Kuie.

In: Asian Pacific Journal of Cancer Prevention, Vol. 13, No. 1, 2012, p. 305-308.

Research output: Contribution to journalArticle

Low, Jeffrey Jen Hui ; Ko, Yu ; Ilancheran, Arunachalam ; Zhang, Xu Hao ; Singhal, Puneet K. ; Tay, Sun Kuie. / Health and economic burden of hpv-related diseases in singapore. In: Asian Pacific Journal of Cancer Prevention. 2012 ; Vol. 13, No. 1. pp. 305-308.
@article{c36dc67be0a44224924094d3606a1f37,
title = "Health and economic burden of hpv-related diseases in singapore",
abstract = "Objective: To assess the health and economic burden of human papillomavirus (HPV)-related diseases (cervical cancer, cervical intraepithelial neoplasia (CIN) 1/2/3, and genital warts) in Singapore over a period of 25 years beginning in 2008. Methods: Incidence-based modeling was used to estimate the incidence cases and associated economic burden, with the assumption that age-stratified incidence rates will remain the same throughout the period of 25 years. The incidence rates in 2008 were projected based on data obtained from the National Cancer Registry for cervical cancer, and from a combination of published data and hospital registry review for CIN1/2/3 and genital warts. The population growth rate was factored into the projection of incidence cases over time. Direct cost data per cervical cancer and per CIN1/2/3 case were obtained from the financial database of large local hospitals while cost data for genital warts were obtained from the National Skin Center; these costs were multiplied by the number of incidence cases to produce an aggregate estimate of the economic burden over the 25-year period (in 2008 Singapore dollars) using a 3{\%} discount rate. Results: The total number of incidence cases of HPV-disease over 25 years beginning in 2008 was estimated to be 60,183, including 8,078 for cervical cancer, 11,685 for CIN 2/3, 8,849 for CIN1, and 31,572 for genital warts. The estimated total direct cost was 83.2 million Singapore Dollars over 25 years: 57.6 million attributable to cervical cancer, 13.0 million to CIN2/3, 6.83 million to CIN1, and 5.70 million to genital warts. Conclusion: HPV-related diseases are expected to impose significant health and economic burden on the Singapore healthcare resources in the next 25 years.",
keywords = "Cost of illness, Human papillomavirus, Singapore",
author = "Low, {Jeffrey Jen Hui} and Yu Ko and Arunachalam Ilancheran and Zhang, {Xu Hao} and Singhal, {Puneet K.} and Tay, {Sun Kuie}",
year = "2012",
doi = "10.7314/APJCP.2012.13.1.305",
language = "English",
volume = "13",
pages = "305--308",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "1",

}

TY - JOUR

T1 - Health and economic burden of hpv-related diseases in singapore

AU - Low, Jeffrey Jen Hui

AU - Ko, Yu

AU - Ilancheran, Arunachalam

AU - Zhang, Xu Hao

AU - Singhal, Puneet K.

AU - Tay, Sun Kuie

PY - 2012

Y1 - 2012

N2 - Objective: To assess the health and economic burden of human papillomavirus (HPV)-related diseases (cervical cancer, cervical intraepithelial neoplasia (CIN) 1/2/3, and genital warts) in Singapore over a period of 25 years beginning in 2008. Methods: Incidence-based modeling was used to estimate the incidence cases and associated economic burden, with the assumption that age-stratified incidence rates will remain the same throughout the period of 25 years. The incidence rates in 2008 were projected based on data obtained from the National Cancer Registry for cervical cancer, and from a combination of published data and hospital registry review for CIN1/2/3 and genital warts. The population growth rate was factored into the projection of incidence cases over time. Direct cost data per cervical cancer and per CIN1/2/3 case were obtained from the financial database of large local hospitals while cost data for genital warts were obtained from the National Skin Center; these costs were multiplied by the number of incidence cases to produce an aggregate estimate of the economic burden over the 25-year period (in 2008 Singapore dollars) using a 3% discount rate. Results: The total number of incidence cases of HPV-disease over 25 years beginning in 2008 was estimated to be 60,183, including 8,078 for cervical cancer, 11,685 for CIN 2/3, 8,849 for CIN1, and 31,572 for genital warts. The estimated total direct cost was 83.2 million Singapore Dollars over 25 years: 57.6 million attributable to cervical cancer, 13.0 million to CIN2/3, 6.83 million to CIN1, and 5.70 million to genital warts. Conclusion: HPV-related diseases are expected to impose significant health and economic burden on the Singapore healthcare resources in the next 25 years.

AB - Objective: To assess the health and economic burden of human papillomavirus (HPV)-related diseases (cervical cancer, cervical intraepithelial neoplasia (CIN) 1/2/3, and genital warts) in Singapore over a period of 25 years beginning in 2008. Methods: Incidence-based modeling was used to estimate the incidence cases and associated economic burden, with the assumption that age-stratified incidence rates will remain the same throughout the period of 25 years. The incidence rates in 2008 were projected based on data obtained from the National Cancer Registry for cervical cancer, and from a combination of published data and hospital registry review for CIN1/2/3 and genital warts. The population growth rate was factored into the projection of incidence cases over time. Direct cost data per cervical cancer and per CIN1/2/3 case were obtained from the financial database of large local hospitals while cost data for genital warts were obtained from the National Skin Center; these costs were multiplied by the number of incidence cases to produce an aggregate estimate of the economic burden over the 25-year period (in 2008 Singapore dollars) using a 3% discount rate. Results: The total number of incidence cases of HPV-disease over 25 years beginning in 2008 was estimated to be 60,183, including 8,078 for cervical cancer, 11,685 for CIN 2/3, 8,849 for CIN1, and 31,572 for genital warts. The estimated total direct cost was 83.2 million Singapore Dollars over 25 years: 57.6 million attributable to cervical cancer, 13.0 million to CIN2/3, 6.83 million to CIN1, and 5.70 million to genital warts. Conclusion: HPV-related diseases are expected to impose significant health and economic burden on the Singapore healthcare resources in the next 25 years.

KW - Cost of illness

KW - Human papillomavirus

KW - Singapore

UR - http://www.scopus.com/inward/record.url?scp=84864885018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864885018&partnerID=8YFLogxK

U2 - 10.7314/APJCP.2012.13.1.305

DO - 10.7314/APJCP.2012.13.1.305

M3 - Article

C2 - 22502690

AN - SCOPUS:84864885018

VL - 13

SP - 305

EP - 308

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 1

ER -